Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 6—June 2007


Endemic Human Monkeypox, Democratic Republic of Congo, 2001–2004

Anne W. Rimoin*, Neville Kisalu†, Benoit Kebela-Ilunga‡, Thibaut Mukaba†, Linda L. Wright§, Pierre Formenty¶, Nathan D. Wolfe#, Robert Loshima Shongo‡, Florimond Tshioko**, Emile Okitolonda††, Jean-Jacques Muyembe†, Robert W. Ryder‡‡, and Hermann Meyer§§Comments to Author 
Author affiliations: *University of California, Los Angeles, California, USA; †National Institute of Biomedical Research, Kinshasa, Democratic Republic of Congo; ‡Ministry of Health, Kinshasa, Democratic Republic of Congo; §National Institutes of Health, Bethesda, Maryland, USA; ¶World Health Organization, Geneva, Switzerland; #Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; **World Health Organization, Kinshasa, Democratic Republic of Congo; ††Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo; ‡‡University of North Carolina, Chapel Hill, North Carolina, USA; §§Bundeswehr Institute of Microbiology, Munich, Germany;

Main Article

Table 2

Age and sex distribution of patients with monkeypox or chickenpox, Democratic Republic of Congo, 2001–2004*

Age, y No. cases investigated male/female, n = 134 MPX-positive male/female, n = 51 VZV-positive male/female, n = 61
<4 12/21 8/7 3/6
5–14 22/19 12/9 7/8
15–24 17/13 5/7† 10/5†
25–34 9/8 2/0 5/6
>35 6/7 1/0 5/6
Total 66/68 28/23 30/31

*MPX, monkeypox; VZV, varicella-zoster virus.
†Coinfection with MPX and VZV in a 17-year-old female patient.

Main Article